SCHEMBL30817400

SCHEMBL30817400

O=C1CCC(c2cccc(CN3CC4(CC(CO)C4)C3)c2)C(=O)N1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 18/20 0.48
▸ DDB1 Q16531 17/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30817391 0.87 CRBN (0.52) CRBNDDB1
SCHEMBL30817351 0.84 CRBN (0.45) CRBNDDB1
SCHEMBL30830925 0.80 CRBN (0.58) CRBNDDB1
SCHEMBL26641343 0.76 CRBN (0.60) CRBNDDB1
SCHEMBL30643548 0.76 CRBN (0.60) CRBNDDB1
SCHEMBL24207221 0.76 CRBN (0.57) CRBNDDB1
SCHEMBL24548362 0.76 CRBN (0.63) CRBNDDB1
SCHEMBL25822350 0.74 CRBN (0.65) CRBNDDB1
SCHEMBL27293173 0.74 CRBN (0.52) CRBNDDB1
SCHEMBL25482344 0.73 CRBN (0.56) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059808-A1 WEE1 INHIBITORS AND METHODS FOR TREATING CANCER RECURIUM IP HOLDINGS, LLC (US) 2024-03-21 — — WO disclosed
Send feedback